NCT03833687View on ClinicalTrials.gov

Aesthetic Performance of an Injective Treatment for the Skin Roughness and Laxity of Inner Arm and Abdomen

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 11, 2018

Primary Completion Date

February 6, 2019

Study Completion Date

February 6, 2019

Conditions
Skin Flaccidity and Roughness of the Abdomen and Inner Arms
Interventions
DEVICE

Profhilo®

Profhilo® (IBSA Farmaceutici Italia S.r.l.) is a resorbable medical device 2.25 ml non-pyrogenic pre-filled syringe, containing 2 ml of 3.2% hyaluronic acid for intradermal use (32 mg H-HA + 32 mg L-HA dissolved in 2 ml of saline buffered sodium chloride.

Trial Locations (1)

20159

DERMING, Milan

Sponsors

Lead Sponsor

Derming SRL
All Listed Sponsors
lead

Derming SRL

OTHER

NCT03833687 - Aesthetic Performance of an Injective Treatment for the Skin Roughness and Laxity of Inner Arm and Abdomen | Biotech Hunter | Biotech Hunter